Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) announced it will present data from the open-label extension phase of its ongoing Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE